Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease

Neurobiology of Aging

Volumn 24, Issue 7, 2003, Pages 915-919

  Rinaldi, P ^a   Polidori, M C ^b   Metastasio, A ^a   Mariani, E ^a   Mattioli, P ^a   Cherubini, A ^a   Catani, M ^a   Cecchetti, R ^a   Senin, U ^a   Mecocci, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Antioxidants; Mild cognitive impairment; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; ENZYME; GLUTATHIONE PEROXIDASE; LYCOPENE; RETINOL; SUPEROXIDE DISMUTASE; TRACE ELEMENT; UNCLASSIFIED DRUG; URIC ACID; WATER; XANTHOPHYLL; ZEAXANTHIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPOPHILICITY; MALE; MEDICAL ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SOLUBILITY;

EID: 0042591280     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00031-9     Document Type: Article

References (42)

1. American Psychiatry Society. DSM-IV Diagnostic and statistical manual of mental disorders. 4th ed. 1994.
2. Azzi A., Stocker R. Vitamin E: non-antioxidant roles. Prog. Lipid Res. 39(3):2000;231-255.
3. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
4. Berger T., Polidori M.C., Dabbagh A., Evans P., Halliwell B., Morrow J.et al. Antioxidant activity of Vitamin C in iron-overloaded human plasma. J. Biol. Chem. 272(25):1997;15656-15660.
5. Berr C., Balansard B., Arnaud J., Roussel A.M. Alperovitch A for the EVA study group: cognitive decline is associated with systemic oxidative stress: the EVA study. J. Am. Geriatr. Soc. 48(10):2000;1285-1291.
6. Bourdel-Marchasson I., Delmas-Beauvieux M.C., Peuchant E., Richard-Harston S., Decamps A., Reignier B.et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer's patients. Age Ageing. 30(3):2001;235-241.
7. Butterfield D.A., Koppal T., Subramanian R., Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid β-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev. Neurosci. 10(2):1999;141-149.
8. Chandra R.K. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition. 17(9):2001;709-712.
9. Christen Y. Oxidative stress and Alzheimer's disease. Am. J. Clin. Nutr. 71(2):2000;621S-629S.
10. Cuajungco M.P., Faget K.Y., Huang X., Tanzi R.E., Bush A.I. Metal chelation as a potential therapy for Alzheimer's disease. Ann. N.Y. Acad. Sci. 920:2000;292-304.
11. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C.et al. Dietary intake of antioxidants and risk of Alzheimer's disease. JAMA. 287(24):2002;3223-3229.
12. Flohé L., Günzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105:1984;114-121.
13. Frei B., England L., Ames B.N. Ascorbate is an outstanding antioxidant in human plasma. Proc. Natl. Acad. Sci. U.S.A. 86(16):1989;6377-6381.
14. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F.et al. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156(1):2000;15-20.
15. Hixson J.E., Venier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31(3):1990;545-548.
16. Kutnink M.A., Hawkes W.C., Schaus E.E., Omaye S.T. An internal standard method for the unattended high-performance liquid analysis of ascorbic acid in blood components. Anal. Biochem. 166(2):1987;424-430.
17. L'Abbé M.R., Fisher P.W.F. Automated assay of superoxide dismutase in blood. Methods Enzymol. 186:1990;232-237.
18. Levy R. Aging associated cognitive decline working party of the international psychogeriatric association in collaboration with the world health organization. Int. Psycogeriatr. 6(1):1994;63-68.
19. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 9(1):1999;133-146.
20. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17(7):1997;2284-2294.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34(7):1984;939-944.
22. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36(5):1994;747-751.
23. Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M.et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer's disease. Arch. Neurol. 59(5):2002;794-798.
24. Mecocci P., Polidori M.C., Ingegni T., Cherubini A., Chionne F., Cecchetti R.et al. Oxidative damage to DNA in lymphocytes from AD patients. Neurology. 51(4):1998;1014-1017.
25. Mendelsohn A.B., Belle S.H., Stoehr G.P., Ganguli M. Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela valley independent elders survey. Am. J. Epidemiol. 148(1):1998;38-44.
26. Meydani M. Antioxidants and cognitive function. Nutr. Rev. 59(8):2001;S75-S82.
27. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H.et al. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch. Neurol. 58(3):2001;397-405.
28. Nierenberg D.W., Nann S.L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am. J. Clin. Nutr. 56(2):1992;417-426.
29. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K.et al. Oxidative damage is the earliest event in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60(8):2001;759-767.
30. Ortega R.M., Requejo A.M., Lopez-Sobaler A.M., Andres P., Navia B., Perea J.M.et al. Cognitive function in elderly people is affected by Vitamin E status. J. Nutr. 132(7):2002;2065-2068.
31. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V.et al. Current concepts in mild cognitive impairment. Arch. Neurol. 58(12):2001;1985-1992.
32. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56(3):1999;303-308.
33. Polidori M.C., Stahl W., Eichler O., Niestroj I., Sies H. Profiles of antioxidants in human plasma. Free Radic. Biol. Med. 30(5):2001;456-462.
34. Praticò D., Clark C.M., Liun F., Lee V.Y., Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer's disease. Arch. Neurol. 59(5):2002;972-976.
35. Praticò D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21(12):2001;4183-4187.
36. Riviere S., Birlouez-Aragon I., Nourhashemi F., Vellas B. Low plasma Vitamin C in Alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry. 13(11):1998;749-754.
37. Sayre L.M., Perry G., Atwood C.S., Smith M.A. The role of metals in neurodegenerative diseases. Cell Mol. Biol. 46(4):2000;731-741.
38. Schmidt R., Hayn M., Reinhart B., Roob G., Schmidt H., Schumacher M.et al. Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian stroke prevention study. J. Am. Geriatr. Soc. 46(11):1998;1407-1410.
39. Smith M.A., Nunomura A., Zhu X., Takeda A., Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer's disease. Antioxid. Redox Signal. 2(3):2000;413-420.
40. Stahl W., Junghans A., de Boer B., Driomina E.S., Briviba K., Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett. 427:1998;305-308.
41. Stahl W., Sundquist A.R., Hanusch M., Schwarz W., Sies H. Separation of β-carotene and lycopene geometrical isomers in biological samples. Clin. Chem. 39:1993;810-814.
42. Winterbourn C.C., Hawkins E.R., Brian M., Carrell W.R. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 85:1972;337-341.